• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Prolonged course of Fosfomycin-Trometamol for chronic prostatitis: an unknown good option
CONCLUSION: Fosfomycin-Trometamol can be a good option for the treatment of bacterial prostatitis when other antibiotics can't be used either for resistance or allergy.PMID:34060413 | DOI:10.1080/21681805.2021.1933170
Source: Scandinavian Journal of Urology - June 1, 2021 Category: Urology & Nephrology Authors: Eric Denes Source Type: research

Pneumocystis jiroveci.
Abstract Pneumocystis jiroveci remains an important fungal pathogen in a broad range of immunocompromised hosts. The natural reservoir of infection remains unknown. Pneumocystis jiroveci Pneumonia (PJP) develops via airborne transmission or reactivation of inadequately treated infection. Nosocomial clusters of infection have been described among immunocompromised hosts. Subclinical infection or colonization may occur. Pneumocystis pneumonia occurs most often within 6 months of organ transplantation and with intensified or prolonged immunosuppression, notably with corticosteroids. Infection is also common during ne...
Source: Respiratory Care - January 31, 2020 Category: Respiratory Medicine Authors: Fishman JA Tags: Semin Respir Crit Care Med Source Type: research

Pneumocystis jiroveci
Semin Respir Crit Care Med 2020; 41: 141-157 DOI: 10.1055/s-0039-3399559 Pneumocystis jiroveci remains an important fungal pathogen in a broad range of immunocompromised hosts. The natural reservoir of infection remains unknown. Pneumocystis jiroveci Pneumonia (PJP) develops via airborne transmission or reactivation of inadequately treated infection. Nosocomial clusters of infection have been described among immunocompromised hosts. Subclinical infection or colonization may occur. Pneumocystis pneumonia occurs most often within 6 months of organ transplantation and with intensified or prolonged immunosuppression, notabl...
Source: Seminars in Respiratory and Critical Care Medicine - January 29, 2020 Category: Respiratory Medicine Authors: Fishman, Jay A. Tags: Review Article Source Type: research

Silver nanoparticles as a therapeutic agent in experimental cyclosporiasis.
In this study, silver nanoparticles were chemically synthesized to be evaluated for the first time for their anti-cyclospora effects in both immunocompetent and immunosuppressed experimental mice in comparison to the standard treatment. The effect of silver nanoparticles was assessed through studying stool oocyst load, oocyst viability, ultrastructural changes in oocysts, and estimation of serum gamma interferon. Toxic effect of the therapeutic agents was evaluated by measuring liver enzymes, urea and creatinine in mouse sera. Results showed that silver nanoparticles had promising anti-cyclospora potentials. The animals th...
Source: Experimental Parasitology - October 10, 2019 Category: Parasitology Authors: Gaafar MR, El-Zawawy LA, El-Temsahy MM, Shalaby TI, Hassan AY Tags: Exp Parasitol Source Type: research